Revision to Prior Period Financial Statements (Tables)

3 Months Ended

Mar. 31, 2021


	As of March 18, 2021
	As Previously Reported			Restatement Adjustment			As Restated
Balance Sheet
Total assets	$	981,444,800		$	—		$	981,444,800

Liabilities and stockholders’ equity
Total current liabilities	$	2,015,571		$	—		$	2,015,571
Deferred legal fees		18,183			—			18,183
Deferred underwriting commissions		34,212,500						34,212,500
Derivative warrant liabilities		—			35,160,700			35,160,700

Total liabilities		36,246,254			35,160,700			71,406,954
Class A common stock, $0.0001 par value; shares subject to possible redemption		940,198,540			(35,160,700	)		905,037,840
Stockholders’ equity
Preferred stock- $0.0001 par value		—			—			—
Class A common stock—$0.0001 par value		373			352			725
Class B common stock—$0.0001 par value		2,444			—			2,444
Additional paid-in-capital		5,087,286			1,111,128			6,198,414
Accumulated deficit		(90,097	)		(1,111,480	)		(1,201,577	)

Total stockholders’ equity		5,000,006			—			5,000,006

Total liabilities and stockholders’ equity	$	981,444,800		$	—		$	981,444,800